US Stocks
/
Kyverna Therapeutics, Inc. Share Price
Kyverna Therapeutics, Inc. Share Price

Kyverna Therapeutics, Inc. Share Price

NASDAQ: KYTX | Micro Cap
$6.39
+$0.19 (3.15%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kyverna Therapeutics, Inc. Stock Performance

Open
$6.20
Prev. Close
$6.20
Circuit Range
N/A
Day Range
$6.18 - $6.57
Year Range
$5.97 - $13.60
Volume
27,857
Average Traded
$6.39

Kyverna Therapeutics, Inc. Share Price Today

As of 10 October 2026, Kyverna Therapeutics, Inc.'s share price is $6.39. The stock opened at $6.20, compared to its previous close of $6.20. During today's trading session, Kyverna Therapeutics, Inc.'s share price traded between $6.18 and $6.57, with an average price of $6.38. Over the past 52 weeks, the stock has recorded a high of $13.60 and a low of $5.97. In terms of performance, Kyverna Therapeutics, Inc.'s share price has declined by 27.63% over the last six months and is down 8.19% on a year-on-year basis.

Kyverna Therapeutics, Inc. Share Price Chart

$6.18$6.57
L
Show Current Price
H

Kyverna Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$282.82M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.47
Revenue (TTM)
$0.00
Return On Equity (TTM)
-92.20%
Profit Margin
N/A
Debt to Equity
0.15
Quarterly Earnings Growth YoY
-4.16%

Kyverna Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$36.79-$37.80-$39.73-$38.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-2.75%-5.11%3.55%

Kyverna Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$127.48-$161.31
Net Profit MarginN/AN/A
Income ChangeN/A-26.54%

About Kyverna Therapeutics, Inc.

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Kyverna Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$6.74
$6.40
-6.23%
Sep 2026
$8.28
$6.83
-20.96%
Aug 2026
$7.30
$8.63
+18.29%
Jul 2026
$8.91
$7.30
-17.98%
Jun 2026
$8.46
$8.90
+4.64%
May 2026
$8.77
$8.51
-3.68%
Apr 2026
$8.66
$8.83
+2.08%
Mar 2026
$7.88
$8.65
+5.23%
Feb 2026
$7.91
$8.22
+2.62%
Jan 2026
$9.46
$8.01
-14.61%
Dec 2025
$7.38
$9.38
+21.82%
Nov 2025
$6.98
$7.70
+10.63%

KYTX Share Price FAQs

What is Kyverna Therapeutics, Inc. share price today?

chevron-up
Kyverna Therapeutics, Inc. share price today is $6.39 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Kyverna Therapeutics, Inc. stock?

chevron-up
The 52 week high of Kyverna Therapeutics, Inc. stock is $13.60, while the 52 week low is $5.97 as of 10 Oct '26.

What is KYTX's market capitalisation today?

chevron-up
KYTX market capitalisation is $282.82M as of October 10, 2026, at 4:41 am IST.

What is KYTX's net income for the last quarter?

chevron-up
KYTX's net income for the last quarter is -38.32B USD.

What is the 5 year returns of KYTX?

chevron-up
The 5 year returns of KYTX is -76.48% as on 10 Oct '26.

What is the high & low stock price of KYTX today?

chevron-up
KYTX stock price hit a high of $6.57 and low of $6.18 as of 10 Oct '26.

Can I buy KYTX shares in India?

chevron-up
Yes. You can buy KYTX in India by opening an international trading account.